We are live on
!
Find out more
OMERS Administration Corp Portfolio holdings
AUM
$16.7B
Turnover
31.48%
1-Year Est. Return
35.95%
This Fund
S&P 500
This Quarter
Est. Return
-2.21%
1 Year Est. Return
+35.95%
3 Year Est. Return
+106.41%
5 Year Est. Return
+114.67%
10 Year Est. Return
+344.51%
AUM
$15.6B
AUM Growth
+$1.52B
(+11%)
Cap. Flow
+$2.38B
Cap. Flow
% of AUM
15.32%
Top 10 Holdings %
Top 10 Hldgs %
34.79%
Holding
1,205
New
175
Increased
591
Reduced
154
Closed
109
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$993M |
| 2 |
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
|
+$414M |
| 3 |
Coca-Cola
KO
|
+$242M |
| 4 |
AstraZeneca
AZN
|
+$159M |
| 5 |
Merck
MRK
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BBU
Brookfield Business Partners
BBU
|
+$424M |
| 2 |
Waste Connections
WCN
|
+$184M |
| 3 |
Broadcom
AVGO
|
+$153M |
| 4 |
Nike
NKE
|
+$150M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Financials | 16.4% |
| 3 | Industrials | 10.28% |
| 4 | Healthcare | 9.9% |
| 5 | Miscellaneous | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
976
Black Diamond Therapeutics
BDTX
$98.2M
| $134K | ﹤0.01% |
62,800
-76,100
| -55% | -$181K |
2025 Q3
2 quarters
|
|
977
RF Industries
RFIL
$76.2M
| $131K | ﹤0.01% |
+12,700
| New | +$129K |
2026 Q1
0 quarters
|
|
978
Tencent Music
TME
$14.1B
| $131K | ﹤0.01% |
14,079
| – | – |
2025 Q3
2 quarters
|
|
979
Ampco-Pittsburgh
AP
$171M
| $130K | ﹤0.01% |
+19,300
| New | +$139K |
2026 Q1
0 quarters
|
|
980
UiPath
PATH
$6.69B
| $128K | ﹤0.01% |
11,537
| – | – |
2024 Q2
7 quarters
|
|
981
GigCapital9 Corp Units
GIXXU
| $128K | ﹤0.01% |
+12,717
| New | +$128K |
2026 Q1
0 quarters
|
|
982
Kyverna Therapeutics
KYTX
$356M
| $128K | ﹤0.01% |
14,800
-20,000
| -57% | -$167K |
2025 Q4
1 quarter
|
|
|
CGCTU
983
DELISTED
Cartesian Growth Corp III Unit
CGCTU
| $128K | ﹤0.01% |
12,060
| – | – |
2025 Q4
1 quarter
|
|
984
Tigo Energy
TYGO
$64M
| $125K | ﹤0.01% |
33,200
-130,400
| -80% | -$431K |
2025 Q4
1 quarter
|
|
985
BRC Group Holdings
RILY
$184M
| $124K | ﹤0.01% |
17,000
-70,600
| -81% | -$527K |
2025 Q4
1 quarter
|
|
986
1stdibs.com
DIBS
$144M
| $122K | ﹤0.01% |
22,100
-54,203
| -71% | -$300K |
2025 Q4
1 quarter
|
|
987
ProKidney
PROK
$278M
| $122K | ﹤0.01% |
67,900
-56,500
| -45% | -$120K |
2025 Q4
1 quarter
|
|
988
Amtech Systems
ASYS
$226M
| $121K | ﹤0.01% |
10,400
-6,200
| -37% | -$83.5K |
2025 Q4
1 quarter
|
|
989
InfuSystem Holdings
INFU
$266M
| $119K | ﹤0.01% |
12,900
-25,500
| -66% | -$223K |
2025 Q4
1 quarter
|
|
990
Upexi
UPXI
$79.8M
| $119K | ﹤0.01% |
120,800
+19,600
| +19% | +$26.3K |
2025 Q4
1 quarter
|
|
991
Immuneering
IMRX
$236M
| $118K | ﹤0.01% |
22,400
-25,400
| -53% | -$130K |
2025 Q4
1 quarter
|
|
992
FreightCar America
RAIL
$195M
| $116K | ﹤0.01% |
14,600
-17,100
| -54% | -$194K |
2025 Q4
1 quarter
|
|
993
Agenus
AGEN
$273M
| $116K | ﹤0.01% |
34,700
-65,800
| -65% | -$218K |
2025 Q4
1 quarter
|
|
994
FuelCell Energy
FCEL
$1.02B
| $116K | ﹤0.01% |
17,700
-16,500
| -48% | -$127K |
2025 Q4
1 quarter
|
|
995
One Stop Systems
OSS
$149M
| $115K | ﹤0.01% |
15,200
-33,000
| -68% | -$308K |
2025 Q4
1 quarter
|
|
996
New Providence Acquisition Corp III Units
NPACU
$284M
| $115K | ﹤0.01% |
11,062
| – | – |
2025 Q3
2 quarters
|
|
997
Climb Bio
CLYM
$566M
| $114K | ﹤0.01% |
16,700
-68,766
| -80% | -$397K |
2025 Q4
1 quarter
|
|
998
Elicio Therapeutics
ELTX
$42.5M
| $114K | ﹤0.01% |
10,700
-12,800
| -54% | -$124K |
2025 Q4
1 quarter
|
|
999
SAB Biotherapeutics
SABS
$237M
| $114K | ﹤0.01% |
29,700
-12,300
| -29% | -$49K |
2025 Q4
1 quarter
|
|
1000
Ondas Inc
ONDS
$3.49B
| $113K | ﹤0.01% |
12,500
-12,400
| -50% | -$135K |
2025 Q4
1 quarter
|
|
Similar funds
NMO
OMERS Administration Corp's Q1 2026 Portfolio in Review
As of Q1 2026, OMERS Administration Corp held 1,205 positions worth $15.6B, up 11% from $14B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
OMERS Administration Corp deployed $2.38B of net new capital in Q1 2026, opening 175 new positions and adding to 591 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 1,587,839 shares worth $949M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Waste Connections, an estimated $184M trimmed.
- OMERS Administration Corp's largest Q1 2026 buy was Vanguard S&P 500 ETF: 1,587,839 shares worth $949M.
- OMERS Administration Corp added most to Brookfield Business Corp Class A Subordinate Voting Shares in Q1 2026, an estimated $414M increase.
- OMERS Administration Corp's biggest Q1 2026 reduction was Waste Connections, cutting an estimated $184M.
- OMERS Administration Corp fully exited Brookfield Business Partners in Q1 2026, selling an estimated $424M.
- OMERS Administration Corp's ten largest holdings make up 35% of its $15.6B portfolio in Q1 2026.
- OMERS Administration Corp opened 175 new positions and closed 109 in Q1 2026.
- OMERS Administration Corp's portfolio value rose 11% quarter-over-quarter to $15.6B.
Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.